News

Corticosteroids, a commonly prescribed medication to alleviate cancer-related symptoms for non-small cell lung cancer ...
Generally, fighting cancer is about delivering a relentless attack on the spreading disease, but a new approach explores the ...
As federal funding changes hit universities, key research initiatives are scrambling to find cash. The Schroeder Lab at UA is ...
New research reveals that excess weight is linked to an especially high risk of developing breast cancer in postmenopausal ...
Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...
The molecule, developed by its biotech division Sathgen Therapeutics, is currently undergoing Phase 1a clinical trials.
Linda De Jesus, IDT Vice President and General Manager, Global Head of Commercial.
The Korea Research Institute of Standards and Science (KRISS, President Lee Ho Seong) has successfully developed a ...
Ovarian cancer often starts in the fallopian tubes. That's why Mayo Clinic researchers started a living fallopian tube ...
A promising study on preventing metastatic breast cancer has been paused due to a federal stop-work order, according to Weill ...